CCI
NPTN

Columbus Circle Investors’s NEOPHOTONICS CORP NPTN Stock Holding History

Columbus Circle Investors’s Portfolio NPTN Stock Details NPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-37,052
Closed -$286K – 319
2017
Q2 		$286K Buy
+37,052
New +$313K ﹤0.01% 240

Other funds holding NPTN

OMC
Oak Management Corp Wilton, Connecticut $3.24M AUM 83.68% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
QAM
Quentec Asset Management New York $634M AUM 22.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return

Columbus Circle Investors's NPTN Position: Q3 2017 in Review

Columbus Circle Investors sold out of NEOPHOTONICS CORP (NPTN) in Q3 2017, closing a stake of 37,052 shares — an estimated $286K sold.

Columbus Circle Investors first reported a position in NPTN in Q2 2017 and held it in 1 quarter. The position peaked at $286K in Q2 2017. 97 funds tracked by Wall St. Rank hold NPTN as of Q3 2017.

  • Columbus Circle Investors reported no remaining NEOPHOTONICS CORP position as of Q3 2017 after selling out during the quarter.
  • Columbus Circle Investors sold 37,052 NEOPHOTONICS CORP shares in Q3 2017, an estimated $286K.
  • Columbus Circle Investors first reported a position in NEOPHOTONICS CORP in Q2 2017 and held it in 1 quarter.
  • Columbus Circle Investors's NEOPHOTONICS CORP position peaked at $286K in Q2 2017.
  • 97 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2017.

Based on Columbus Circle Investors's 13F filing for Q3 2017, filed 8 Nov 2017.